WEBINAR: Knowledge Translation as a System with Dr Tamika Heiden
Knowledge Translation Australia
Knowledge Translation (KT), one of many terms for translation involves a complex system of interactions among researchers and research users to ensure relevance and to accelerate the capture of research benefits through more effective services and products. KT is underpinned by an evidence base of processes, models, and frameworks.
The terminology of impact and translation was introduced by funders, but the question of how this can be achieved still remains. The advantages of implementing KT strategies are increased opportunities to create impact and to work closely with key organisations and policy stakeholders. Working in partnership with research users from conception can provide mechanisms to ensure your research makes a difference, with the partners being the drivers for change in policy and practice. This webinar will highlight how translation is a system of processes that lead to & enable research impact. The processes, planning, and barriers associated with achieving research impact through a KT system will be presented plus an example of where KT methodologies have led to positive and measurable impact.
About Dr Tamika Heiden
Dr Tamika Heiden is Principal of Knowledge Translation Australia Pty Ltd. She has over a decade of experience as a researcher and research manager in health, sport & medical research that began with a sports science degree and PhD in Biomechanics. She is certified in Knowledge Translation from the University of Toronto, is an Adjunct Research Fellow at the University of Western Australia and has a formal partnership with SickKids Hospital in Toronto.
Tamika brings a breadth of knowledge from both academic and non-academic backgrounds nationally and internationally. She has bought together researchers and research users to share, create and translate knowledge, and works with many government and non-government organisations to facilitate high-level overviews and strategic thinking, including where she gave evidence to the Senate Committee enquiry for the Medical Research Future Fund in Australia.